The congress is accompanied by an exhibition; an important factor in contributing to the congress’s educational function, by allowing participants to gain access to high-quality information and advice.
ECNP would therefore like to invite companies and organisations involved in clinical and pre-clinical research, diagnosis and treatment of disorders of the brain to present their services, products and/or literature at the exhibition, which will be held simultaneously with the congress from Sunday 8 September to Tuesday 10 September 2019.
Coffee and lunch will be served in the exhibition area, to facilitate maximum contact between exhibitors and participants.
For prices and more information please read the exhibition guidelines
List of exhibitors
Below you will find all companies and organisations involved in the exhibition of the 32nd ECNP Congress.
In alphabetical order:
| Brain Science Tools
| ECHO (European Consortium for Observational Studies on Mental Health Products)
| European Brain Council (EBC)
| European Psychiatric Association (EPA)
| Femtonics Ltd.
| H. Lundbeck A/S
| JAMA Network
| Janssen Cilag LTD
| Janssen EMEA
| Janssen Pharmaceutica NV
| MEDICE Arzneimittel Pütter GmbH & Co. KG
| Otsuka Pharmaceutical Europe Ltd and H. Lundbeck A/S
| RECORDATI S.p.A & Gedeon Richter Plc
| Sage Therapeutics, Inc.
| Saladax Biomedical
| SEI Healthcare LLC
| Shire Denmark A/S, part of the Takeda group
| Sunovion Pharmaceuticals Europe
| Wisepress Medical Bookshop
The exhibition floor plan can be viewed here.
The deadline for application for exhibition space was 15 December 2018. The organisers will make initial stand space assignments for applications received before 15 December 2018, taking into account the restrictions of the congress venue and, as much as possible, the applicant’s preferences.
After the initial stand space assignment has been finalised, the remaining space (if available) will be allocated to later applications. No applications will be accepted after 1 July 2019.
If you would like to have more information about late applications, please contact us.